• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    uniQure N.V. - Ordinary Shares (NQ:QURE)

    24.51 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 19,911
    Open 24.51
    Bid (Size) 24.36 (100)
    Ask (Size) 24.61 (1,100)
    Prev. Close 24.51
    Today's Range 24.51 - 24.51
    52wk Range 8.730 - 71.50
    Shares Outstanding 54,865,673
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    uniQure BLA Filed as AMT-130 Shows 4-Year Huntington’s Functional Benefit ↗
    uniQure (NASDAQ:QURE) reported updated Phase I/II data for its investigational Huntington’s disease gene therapy, ifezuntirgene inilparvovec, or AMT-130, including 36-month results from all high-dose... 
    Via MarketBeat
    Top movers analysis one hour before the close of the markets on 2026-09-29: top gainers and losers in today's session. ↗
    Via Chartmill

    Performance

    YTD
    +4.8%
    +4.8%
    1 Month
    -49.7%
    -49.7%
    3 Month
    -46.8%
    -46.8%
    6 Month
    +49.9%
    +49.9%
    1 Year
    -58.7%
    -58.7%

    More News

    Read More
    News headline image
    QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law
    From Schall, Brown & Schwartz LLP
    Via Business Wire
    UniQure (NASDAQ:QURE) Rises on Pipeline Progress Despite Wider Q2 Loss ↗
    Via Chartmill
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    QURE Investor Alert: uniQure Securities Investigation - Kehoe Law Firm, P.C.
    From Kehoe Law Firm
    Via GlobeNewswire
    Traders are paying attention to the gapping stocks in Tuesday's session. ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Tuesday. ↗
    Via Chartmill
    News headline image
    uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression
    From uniQure Inc.
    Via GlobeNewswire
    News headline image
    uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease
    From uniQure Inc.
    Via GlobeNewswire
    News headline image
    uniQure (QURE) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    uniQure Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update
    From uniQure Inc.
    Via GlobeNewswire
    News headline image
    uniQure to Announce Second Quarter 2026 Financial Results
    From uniQure Inc.
    Via GlobeNewswire
    News headline image
    uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
    From uniQure Inc.
    Via GlobeNewswire
    News headline image
    uniQure Announces Pricing of Upsized $225 Million Public Offering
    From uniQure Inc.
    Via GlobeNewswire
    News headline image
    uniQure Announces $150 Million Proposed Public Offering
    From uniQure Inc.
    Via GlobeNewswire
    News headline image
    QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now ↗
    Via InvestorPlace
    News headline image
    uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy
    From uniQure Inc.
    Via GlobeNewswire
    Top movers in Wednesday's session ↗
    Via Chartmill
    These stocks are moving in today's session ↗
    Via Chartmill
    Gapping stocks in Wednesday's session ↗
    Via Chartmill
    Discover the top movers in Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
    From uniQure Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is uniQure N.V. - Ordinary Shares publicly traded?
    Yes, uniQure N.V. - Ordinary Shares is publicly traded.
    What exchange does uniQure N.V. - Ordinary Shares trade on?
    uniQure N.V. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for uniQure N.V. - Ordinary Shares?
    The ticker symbol for uniQure N.V. - Ordinary Shares is QURE on the Nasdaq Stock Market
    What is the current price of uniQure N.V. - Ordinary Shares?
    The current price of uniQure N.V. - Ordinary Shares is 24.51
    When was uniQure N.V. - Ordinary Shares last traded?
    The last trade of uniQure N.V. - Ordinary Shares was at 09/29/26 04:00 PM ET
    What is the market capitalization of uniQure N.V. - Ordinary Shares?
    The market capitalization of uniQure N.V. - Ordinary Shares is 1.34B
    How many shares of uniQure N.V. - Ordinary Shares are outstanding?
    uniQure N.V. - Ordinary Shares has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.